The biotechnology industry is still a growth industry. Investing in an ETF gives me exposure to an industry I don't fully understand. The two major ETFs in the industry have different portfolio ...

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While ...

DUBLIN, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

View post: Amazon is selling a $210 walking pad for just $150 that doubles as a vibration massage pad Biotech stories typically tread a very fine line between promise and pressure. Sometimes a company ...

In the world of biotechnology investing, companies often struggle to bring new drugs to market. Developing treatments for rare diseases can be incredibly expensive, and because these conditions affect ...

Within Utah’s booming tech sector, the state’s rapidly evolving biotechnology industry is being turbocharged by projects like Tech Lake City and BioHive. These initiatives are helping companies that ...

After being mostly down over the past three years, the biotech sector rallied hard to end 2023. The SPDR S&P Biotech ETF (NYSEARCA:XBI) is up 31% in the last three months. From 2010 through 2019, ...

Strong manufacturing base a driving force behind overseas expansion, but industry leaders and analysts say hurdles remain.

For biotech firms, a bit of positive news—a key result from clinical trials or new drug discovery, say—can be the difference between a major rally based on a path toward sustained profitability and a ...